Caeruleus is redefining the boundaries of precision medicine. Harnessing advanced machine learning and proprietary isoform sequencing technologies, we’re pioneering a new era of therapeutic discovery beyond traditional gene expression analysis. Our revolutionary platform is transforming target discovery to develop medicines for millions of patients with unmet clinical needs. We are venture financed by global investors and supported by experienced company builders.

Current Openings